Usage of Antibiotics in Children with Renal Insufficiency

  • Alan B. Gruskin
  • H. Jorge Baluarte
  • Martin A. Polinsky
  • James W. Prebis
  • Abdelaziz Y. Elzouk


The control of infection remains an important aspect of treatment in patients with renal insufficiency. A large fraction of deaths associated with acute renal failure as well as the three phases of end stage renal disease, the period of chronic uremia, dialysis and transplantation, are due to infection. A large fraction of patients with renal disease need antibiotics for treating bacterial infections exclusive of urinary tract infection. Little data is available in children with renal failure on the incidence of infection or its treatment with anti-infectious agents. In a recent survey of our transplantation experience involving 107 transplants at St. Christopher’s Hospital for Children, positive blood cultures were obtained in 10 patients in the initial 21 days following the transplant (1). Moreover, antibiotics have been administered for a variety of infectious problems to virtually all of our patients with end stage renal disease. In one report of 497 children undergoing maintenance dialysis, infection was responsible for death in 13 percent (2). Thus, the need to understand how best to administer antibiotics to uremic children is obvious.


Peritoneal Dialysis Renal Insufficiency Peritoneal Membrane Maintenance Dialysis Drug Removal 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Fisher, M.L., Baluarte, H.J., Cote, M.L. et al.: Bacteroides fragilis infection in renal allograft recipients. Abstract. 19th Interscience Conference on Antimicrobial Agents & Chemotherapy, October, 1979.Google Scholar
  2. 2.
    Scharer, K., Brunner, F.P., Dehn, H. et al.: Combined report on regular dialysis and transplantation of children in Europe, 1972. Proc. Eur. Dial. Transplant. Assoc. 10: LVIII, 1973.Google Scholar
  3. 3.
    Yoshioka, H., Takimoto, M., Matsuda, I. et al.: Dosage schedule of gentamycin for chronic renal insufficiency in children. Arch. Dis. Child. 53: 334, 1978.PubMedCrossRefGoogle Scholar
  4. 4.
    Jusko, W.J., Baliah, T., Kim, K.H. et al.: Pharmacokinetics of gentamycin during peritoneal dialysis in children. Kidney Int. 9: 430, 1976.PubMedCrossRefGoogle Scholar
  5. 5.
    Hiner, L.B., Baluarte, H.J., Polinsky, M.S. et al.: Cefazolin in children with renal insufficiency. J. Pediatr. 96: 335, 1980.PubMedCrossRefGoogle Scholar
  6. 6.
    Cutler, R.E. and Christopher, T.E.: Drug therapy during renal insufficiency and dialytic treatment. In: Massry, S.E., Sellers, A.L. (eds.). Clinical Aspects of Uremia and Dialysis. Springfield, Ill.: Charles C. Thomas, 1976, p. 427.Google Scholar
  7. 7.
    Gambertoglio, J.G.: Pharmacokinetic principles and renal disease. Dial. & Transplant. 8: 8, 1979.Google Scholar
  8. 8.
    Jusko, W.J.: Pharmacokinetic principles in pediatric pharmacology. Pediatr. Clin. N. Am. 19: 81, 1972.Google Scholar
  9. 9.
    Reidenberg, M.M.: The biotransformation of drugs in renal failure. Am. J. Med. 62: 482, 1977.PubMedCrossRefGoogle Scholar
  10. 10.
    Greene, D.S. and Tice, A.D.: Effect of hemodialysis on cefazolin protein binding. J. Pharmacol. Sci. 66: 1508, 1977.Google Scholar
  11. 11.
    Gulyassy, P.F. and Depner, T.A.: Abnormal drug binding in uremia. Dial. Transplant. 8: 19, 1979.Google Scholar
  12. 12.
    Craig, W.A., Welling, P.G., Jackson, T.C. et al.: Pharmacology of cefazolin and other cephalosporins in patients with renal insufficiency. J. Infect. Dis. 128 (Suppl.): S347, 1973.PubMedCrossRefGoogle Scholar
  13. 13.
    Levison, M.E., Levison, S.P., Ries, K. et al.: Pharmacology of cefazolin in patients with normal and abnormal renal function. J. Infect. Dis. 128 (Suppl.): S354, October, 1973.Google Scholar
  14. 14.
    McCloskey, R.V., Forland, M.F., Sweeney, M.J. et al.: Hemodialysis of cefazolin. J. Infect. Dis. 128 (Suppl.): S358, October, 1973.PubMedCrossRefGoogle Scholar
  15. 15.
    Kirby, W.M.M. and Regamey, C.: Pharmacokinetics of cefazolin compared with four other cephalosporins. J. Infect. Dis. 128 (Suppl.): S341, 1973.PubMedCrossRefGoogle Scholar
  16. 16.
    Schwartz, G.J., Hyacock, G.B., Edelmann, C.M. Jr. et al.: A simple estimate of glomerular filtration rate in children derived from body length and plasma creatinine. Pediatrics 58: 259, 1976.PubMedGoogle Scholar
  17. 17.
    Bennett, W.M., Singer, I., Golper, T. et al.: Guidelines for drug therapy in renal failure. Ann. Intern. Med. 86: 754, 1977.PubMedGoogle Scholar
  18. 18.
    Gibson, T.P.: Dialyzability of common therapeutic agents. Dial. & Transplant. 8: 24, 1979.Google Scholar
  19. 19.
    Golper, T.A.: Drugs and peritoneal dialysis. Dial. & Transplant. 8: 41, 1979.Google Scholar
  20. 20.
    Anderson, R.J., Gambertoglio, J.G. and Schrier, R.W.: The clinical use of drugs in renal failure. Springfield, Ill.: Charles C. Thomas, 1976.Google Scholar
  21. 21.
    Elzouki, A., Gruskin, A.B., Baluarte, H.J. et al.: Age related changes in peritoneal dialysis kinetics. Abst., Society Pediatr. Res. 14: 618, 1980.Google Scholar

Copyright information

© Plenum Press, New York 1981

Authors and Affiliations

  • Alan B. Gruskin
    • 1
  • H. Jorge Baluarte
    • 1
  • Martin A. Polinsky
    • 1
  • James W. Prebis
    • 1
  • Abdelaziz Y. Elzouk
    • 1
  1. 1.Sect. Nephrol, St. Christopher’s Hosp. for Child., Dept. Pediatr.Temple Univ. Sch. Med.PhiladelphiaUSA

Personalised recommendations